SPRO   $0.98  -2.00% Market Closed

Spero Therapeutics Inc
Total Cash 63.53M
totalCashPerShare 1.175
EBITDA 21.01M
Total Debt 4.94M
quickRatio 2.608
currentRatio 2.678
Total Revenue 118.46M
debtToEquity 6.134
Revenue/Share 2.223
ROA 0.104820006
ROE 0.25805
grossProfits
freeCashflow 1.48M
operatingCashflow -14.38M
earningsGrowth
revenueGrowth 2.754
grossMargins 0.37523997
ebitdaMargins 0.17733999
operatingMargins -1.86928
profitMargins 0.14735
enterpriseValue 12.22M
forwardPE -1.1846848
floatShares 40.47M
sharesOutstanding 54.05M
sharesShort 387.07K
sharesShortPriorMonth 385.15K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.20%
heldPercentInstitutions 0.26%
Short Ratio help_outline 2.77%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 1.49
Price To Book help_outline 0.88
earningsQuarterlyGrowth
netIncomeToCommon 17.45M
trailingEps 0.34%
forwardEps -1.11%
enterpriseToEbitda 0.58
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.36 3Q 2024
institutionsCount 59
lastUpdated Nov. 6, 2024, 7:25 p.m.